The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury
Abstract
Traumatic brain injury (TBI) is a significant medical problem with limited treatment options and is one of the main causes of life-long disability. Neuroinflammation orchestrated by activated microglia/macrophages at the site of injury plays a critical role in the onset of many pathological events following TBI, leading to blood brain barrier (BBB) dysfunction, neuronal damage and long term neuronal and behavioral deficits. Current treatment involves intravenous administration of anti-inflammatory drugs which have limited clinical outcomes only when dosed within the early time window after injury. Hence there is an urgent need to develop improved drug delivery systems which have potential to cross impaired BBB, target and deliver drugs selectively to activated microglia/macrophages at the sites of injury, and suppress the detrimental effects of acute inflammation. In this study, we have used Sinomenine (Sino), a potent anti-inflammatory and antioxidant drug conjugated to hydroxyl terminated generation-4 PAMAM dendrimer (D-Sino) as a potential therapy for attenuating early inflammation in TBI. D-Sino conjugates were synthesized using highly robust copper-catalyzed click reaction with high purity. D-Sino conjugates enhanced the intracellular availability of Sino due to their rapid cellular uptake, significantly attenuated early/acute inflammation by suppressing pro-inflammatory cytokines (TNF-α, IL-1β, CCL-3 and IL-6), and reduced oxidative stress (iNOS and NO) in LPS activated murine macrophages (RAW 264.7) by inhibiting NF-κB activation and its nuclear translocation (the root cause for inflammation inception) significantly more as compared to the free drug. Upon systemic administration in a rabbit model of pediatric TBI, D-Sino conjugates specifically targeted activated microglia/macrophages at the site of injury in the brain. Single dose of D-Sino attenuated inflammation in the injured brain areas by suppressing inflammatory cytokines expression whereas free Sino treatment did not demonstrate a significant effect. Together, these results suggest that D-Sino conjugate may open up new avenues for increasing the therapeutic window in the treatment of early inflammation and for improving the efficacy of the drug in TBI. Moreover, this treatment can work in conjunction with current clinical practices such as therapeutic hypothermia and pharmacologically induced coma for many indications associated with TBI, where acute inflammation plays a critical role in disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, excessive release of inflammatory factors causes acute neuronal degeneration, inhibition of neurite regeneration, and aggravation of other pathological processes (Sharma et al., 2020; Doğanyiğit et al., 2022).”
From Complex bioactive nanofibrous dura mater repairs traumatic brain injury (2026) · cites this paper as Sharma et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272
Inflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
Lucas, K., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8425-7 · Cited by 466
Alternative activation of macrophages: immune function and cellular biology
Varin, A., & Gordon, S. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.009 · Cited by 361
Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation.
Sharma, R., Kim, S.-Y., Sharma, A., Zhang, Z., Kambhampati, S. P., Kannan, S., & Kannan, R. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00569 · Cited by 100
Self-citation
Research works printed but not linked: 66
- Kovesdi, 2012, Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury, Front. Neurol., 3, 10.3389/fneur.2012.00111 · DOI · Paper page
- Schimmel, 2017, Neuroinflammation in traumatic brain injury: a chronic response to an acute injury, Brain Circ, 3, 135, 10.4103/bc.bc_18_17 · DOI · Paper page
- Devoto, 2017, Inflammation relates to chronic behavioral and neurological symptoms in military personnel with traumatic brain injuries, Cell Transplant., 26, 1169, 10.1177/0963689717714098 · DOI
- Xiong, 2018, Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities, Chin. J. Traumatol., 21, 137, 10.1016/j.cjtee.2018.02.003 · DOI · Paper page
- Sharma, 2018, Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics, Theranostics, 8, 5529, 10.7150/thno.29039 · DOI · Paper page
- D. Hernadez-Ontiveros, N. Tajiri, S. Acosta, B. Giunta, J. Tan, C. Borlongan, Microglia activation as a biomarker for traumatic brain injury. Front. Neurol. 4 (2013). · DOI · Paper page
- Schmidt, 2005, Closed head injury—an inflammatory disease?, Brain Res. Rev., 48, 388, 10.1016/j.brainresrev.2004.12.028 · DOI · Paper page
- Acosta, 2013, Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model, PLoS One, 8, 10.1371/annotation/a04a7468-d105-42f3-ba47-263ea2864681 · DOI
- Donat, 2017, Microglial activation in traumatic brain injury, Front. Aging Neurosci., 9, 208, 10.3389/fnagi.2017.00208 · DOI · Paper page
- Loane, 2016, Microglia in the TBI brain: the good, the bad, and the dysregulated, Exp. Neurol., 275, 316, 10.1016/j.expneurol.2015.08.018 · DOI · Paper page
- 2019, J. Neurotrauma, 36, 74, 10.1089/neu.2017.5450 · DOI
- Witcher, 2015, Priming the inflammatory pump of the CNS after traumatic brain injury, Trends Neurosci., 38, 609, 10.1016/j.tins.2015.08.002 · DOI · Paper page
- Zhu, 2014, Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury, J. Neuroinflammation, 11, 59, 10.1186/1742-2094-11-59 · DOI · Paper page
- Ziebell, 2010, Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury, Neurotherapeutics, 7, 22, 10.1016/j.nurt.2009.10.016 · DOI · Paper page
- Yamasaki, 1976, Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum, Acta Med. Okayama, 30, 1
- Wang, 2011, Immunosuppressive and anti-inflammatory activities of sinomenine, Int. Immunopharmacol., 11, 373, 10.1016/j.intimp.2010.11.018 · doi:10.1016/j.intimp.2010.11.018
- Zhang, 2019, Sinomenine attenuates traumatic spinal cord injury by suppressing oxidative stress and inflammation via Nrf2 pathway, Neurochem. Res., 44, 763, 10.1007/s11064-018-02706-z · DOI
- Zhu, 2014, Antinociceptive effects of sinomenine in a rat model of neuropathic pain, Sci. Rep., 4, 7270, 10.1038/srep07270 · DOI
- He, 2005, Requirement for ERK activation in sinomenine-induced apoptosis of macrophages, Immunol. Lett., 98, 91, 10.1016/j.imlet.2004.10.027 · doi:10.1016/j.imlet.2004.10.027
- Wu, 2011, Sinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels, Br. J. Pharmacol., 164, 1445, 10.1111/j.1476-5381.2011.01487.x · DOI
- Yang, 2016, Sinomenine provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE pathway, Front. Neurosci., 10, 10.3389/fnins.2016.00580 · DOI
- Yang, 2014, Sinomenine inhibits microglia activation and attenuates brain injury in intracerebral hemorrhage, Mol. Immunol., 60, 109, 10.1016/j.molimm.2014.03.005 · DOI
- Yang, 2016, Sinomenine provides neuroprotection in model of traumatic brain injury via the Nrf2–ARE pathway, Front. Neurosci., 10, 10.3389/fnins.2016.00580 · DOI
- Shi, 2016, Sinomenine enhances microglia M2 polarization and attenuates inflammatory injury in intracerebral hemorrhage, J. Neuroimmunol., 299, 28, 10.1016/j.jneuroim.2016.08.010 · DOI
- Wang, 2007, Sinomenine inhibits activation of rat retinal microglia induced by advanced glycation end products, Int. Immunopharmacol., 7, 1552, 10.1016/j.intimp.2007.07.030 · DOI
- Liu, 2018, Sinomenine protects against E. coli-induced acute lung injury in mice through Nrf2-NF-κB pathway, Biomed. Pharmacother., 107, 696, 10.1016/j.biopha.2018.08.048 · DOI
- Chai, 2012, Design, synthesis and molecular docking studies of sinomenine derivatives, Bioorg. Med. Chem. Lett., 22, 5849, 10.1016/j.bmcl.2012.07.087 · doi:10.1016/j.bmcl.2012.07.087
- Gao, 2019, Exploratory study data for determining the adverse effects of sinomenine plus gabapentin or ligustrazine hydrochloride and the pharmacokinetic insights of sinomenine in plasma and CNS tissue, Data Brief, 27, 104633, 10.1016/j.dib.2019.104633 · doi:10.1016/j.dib.2019.104633
- Tang, 2018, A systematic review on the Sinomenine derivatives, Mini Rev. Med. Chem., 18, 906, 10.2174/1389557517666171123212557 · DOI
- Zhao, 2016, Transdermal permeation and anti-inflammation activities of novel Sinomenine derivatives, Molecules, 21, 1520, 10.3390/molecules21111520 · DOI
- Svenson, 2012, Dendrimers in biomedical applications—reflections on the field, Adv. Drug Deliv. Rev., 64, 102, 10.1016/j.addr.2012.09.030 · DOI · Paper page
- Araújo, 2018, New advances in general biomedical applications of PAMAM dendrimers, Molecules, 23, 2849, 10.3390/molecules23112849 · DOI · Paper page
- Kolhatkar, 2007, Surface acetylation of Polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability, Bioconjug. Chem., 18, 2054, 10.1021/bc0603889 · DOI · Paper page
- Soiberman, 2017, Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation, Biomaterials, 125, 38, 10.1016/j.biomaterials.2017.02.016 · DOI · Paper page
- Guo, 2016, Dendrimers target the ischemic lesion in rodent and primate models of nonarteritic anterior ischemic optic neuropathy, PLoS One, 11
- Nance, 2015, Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury, J. Control. Release, 214, 112, 10.1016/j.jconrel.2015.07.009 · DOI
- Kannan, 2012, Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model, Sci. Transl. Med., 4, 10.1126/scitranslmed.3003162 · DOI · Paper page
- Sharma, 2018, Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation, Bioeng. Transl. Med., 3, 87, 10.1002/btm2.10094 · DOI
- Zhang, 2015, A new rabbit model of pediatric traumatic brain injury, J. Neurotrauma, 32, 1369, 10.1089/neu.2014.3701 · DOI
- Kambhampati, 2015, Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells, Eur. J. Pharm. Biopharm., 95, 239, 10.1016/j.ejpb.2015.02.013 · DOI
- Paulo, 2011, Nanoparticles for intracellular-targeted drug delivery, Nanotechnology, 22, 494002, 10.1088/0957-4484/22/49/494002 · DOI
- Chandra, 2011, Dendrimer–doxorubicin conjugate for enhanced therapeutic effects for cancer, J. Mater. Chem., 21, 5729, 10.1039/c0jm04198j · DOI
- Perumal, 2008, The effect of surface functionality on cellular trafficking of dendrimers, Biomaterials, 29, 3469, 10.1016/j.biomaterials.2008.04.038 · DOI · Paper page
- Alnasser, 2018, Preferential and increased uptake of hydroxyl-terminated PAMAM dendrimers by activated microglia in rabbit brain mixed glial culture, Molecules, 23, 1025, 10.3390/molecules23051025 · DOI
- Bagaev, 2019, Elevated pre-activation basal level of nuclear NF-κB in native macrophages accelerates Lps-induced translocation of cytosolic NF-κB into the cell nucleus, Sci. Rep., 9, 4563, 10.1038/s41598-018-36052-5 · DOI
- Tao, 2015, Platycodin D attenuates acute lung injury by suppressing apoptosis and inflammation in vivo and in vitro, Int. Immunopharmacol., 27, 138, 10.1016/j.intimp.2015.05.005 · DOI
- Shukla, 2011, Sinomenine inhibits microglial activation by Aβ and confers neuroprotection, J. Neuroinflammation, 8, 117, 10.1186/1742-2094-8-117 · DOI
- Llorián-Salvador, 2016, Involvement of CC chemokine receptor 1 and CCL 3 in acute and chronic inflammatory pain in mice, Basic Clin. Pharmacol. Toxicol., 119, 32, 10.1111/bcpt.12543 · DOI
- Gallentine, 2017, Plasma cytokines associated with febrile status epilepticus in children: a potential biomarker for acute hippocampal injury, Epilepsia, 58, 1102, 10.1111/epi.13750 · DOI
- Helmy, 2012, Principal component analysis of the cytokine and chemokine response to human traumatic brain injury, PLoS One, 7, 10.1371/journal.pone.0039677 · DOI
- Johnson, 2013, Inflammation and white matter degeneration persist for years after a single traumatic brain injury, Brain, 136, 28, 10.1093/brain/aws322 · DOI · Paper page
- Zhang, 2018, Traumatic injury leads to inflammation and altered tryptophan metabolism in the juvenile rabbit brain, J. Neurotrauma, 36, 74, 10.1089/neu.2017.5450 · DOI
- Wright, 2014, Very early administration of progesterone for acute traumatic brain injury, N. Engl. J. Med., 371, 2457, 10.1056/NEJMoa1404304 · DOI · Paper page
- Williams, 2007, Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat, J. Neuroinflammation, 4, 17, 10.1186/1742-2094-4-17 · DOI
- Nonaka, 1999, Prolonged activation of NF-κB following traumatic brain injury in rats, J. Neurotrauma, 16, 1023, 10.1089/neu.1999.16.1023 · DOI · Paper page
- Bharadwaj, 2016, Temporal assessment of nanoparticle accumulation after experimental brain injury: effect of particle size, Sci. Rep., 6, 29988, 10.1038/srep29988 · DOI
- Miller, 2019, Evaluating differential nanoparticle accumulation and retention kinetics in a mouse model of traumatic brain injury via Ktrans mapping with MRI, Sci. Rep., 9, 16099, 10.1038/s41598-019-52622-7 · DOI
- Nance, 2016, Nanoscale effects in dendrimer-mediated targeting of neuroinflammation, Biomaterials, 101, 96, 10.1016/j.biomaterials.2016.05.044 · DOI
- Hanlon, 2016, Minocycline transiently reduces microglia/macrophage activation but exacerbates cognitive deficits following repetitive traumatic brain injury in the neonatal rat, J. Neuropathol. Exp. Neurol., 75, 214, 10.1093/jnen/nlv021 · DOI
- Bergold, 2016, Treatment of traumatic brain injury with anti-inflammatory drugs, Exp. Neurol., 275, 367, 10.1016/j.expneurol.2015.05.024 · DOI · Paper page
- Cederberg, 2010, What has inflammation to do with traumatic brain injury?, Childs Nerv. Syst., 26, 221, 10.1007/s00381-009-1029-x · DOI · Paper page
- Schimmel, 2017, Neuroinflammation in traumatic brain injury: a chronic response to an acute injury, Brain Circ, 3, 135, 10.4103/bc.bc_18_17 · DOI · Paper page
- Hinson, 2015, Clinical evidence of inflammation driving secondary brain injury: a systematic review, J. Trauma Acute Care Surg., 78, 184, 10.1097/TA.0000000000000468 · DOI · Paper page
- Yang, 2016, Sinomenine provides neuroprotection in model of traumatic brain injury via the Nrf2–ARE pathway, Front. Neurosci., 10, 580, 10.3389/fnins.2016.00580 · DOI
- Nemeth, 2017, Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic–ischemic insult in neonatal mice: effects of injury, microglial activation and hypothermia, Nanomedicine, 13, 2359, 10.1016/j.nano.2017.06.014 · DOI
- Kannan, 2017, Effect of anesthetics on microglial activation and nanoparticle uptake: implications for drug delivery in traumatic brain injury, J. Control. Release, 263, 192, 10.1016/j.jconrel.2017.03.032 · DOI
Cited by
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Complex bioactive nanofibrous dura mater repairs traumatic brain injury
Chen, S., Zhang, X., Guo, Q., Yan, Y., Fu, M., Wang, Y., & Wu, T. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00621 · Cited by 3
Self-citation
Metadata
- Authors
- Sharma, R., Kambhampati, S. P., Zhang, Z., Sharma, A., Chen, S., Duh, E. I., Kannan, S., Tso, M. O. M., & Kannan, R. M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 323
- Pages
- 361-375
- ISSN
- 0168-3659
- Cited by
- 121
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD076901)
- National Eye Institute (RO1 EY025304)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.